GBP2 and neoplasm: In pancreatic adenocarcinoma, however, high GBP2 forecasts poor survival, tied to immune evasion and acidosis adaptation, quantifiable through RNA sequencing, tissue proteomics, or tumor microenvironment analysis [43,70].